Cargando…

CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction

The Forkhead box protein M1 (FoxM1) is an appealing target for anti-cancer therapeutics as this cell proliferation-associated transcription factor is overexpressed in most human cancers. FoxM1 is involved in tumor invasion, angiogenesis, and metastasis. To discover novel inhibitors that disrupt the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Woo Dae, Lee, Mi Young, Mun, Jihye, Lim, Gyutae, Oh, Kwang-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313426/ https://www.ncbi.nlm.nih.gov/pubmed/35884976 http://dx.doi.org/10.3390/biomedicines10071671

Ejemplares similares

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

Broussoflavonol B from Broussonetia kazinoki Siebold Exerts Anti-Pancreatic Cancer Activity through Downregulating FoxM1
por: Jeong, Ji Hye, et al.
Publicado: (2020)

Silencing of FoxM1 blocks growth, migration and invasion of papillary thyroid carcinoma cells
por: Wang, Xiaotao, et al.
Publicado: (2020)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

FoxM1 Is a General Target for Proteasome Inhibitors
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Deregulation of FoxM1b leads to tumour metastasis
por: Park, Hyun Jung, et al.
Publicado: (2011)

FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter
por: Huang, Chao, et al.
Publicado: (2019)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

Novel functions of FoxM1: from molecular mechanisms to cancer therapy
por: Alvarez-Fernández, Mónica, et al.
Publicado: (2013)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

FoxM1 is a promising candidate target in the treatment of breast cancer
por: Lu, Xiao-Feng, et al.
Publicado: (2017)

An order-to-disorder structural switch activates the FoxM1 transcription factor
por: Marceau, Aimee H, et al.
Publicado: (2019)

FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis
por: Qin, Qin, et al.
Publicado: (2023)

Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
por: Littler, D. R., et al.
Publicado: (2010)

Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation
por: Xiang, D, et al.
Publicado: (2014)

Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease
por: Xie, Yanyan, et al.
Publicado: (2023)

Analysis of survivin, XIAP and FoxM1 as potential chemoresistance factors in breast cancer cells
por: Moraes, Gabriela N, et al.
Publicado: (2013)

FoxM1 Promotes Glioma Cells Progression by Up-Regulating Anxa1 Expression
por: Cheng, Shi-Xiang, et al.
Publicado: (2013)

FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion
por: Zheng, Yun, et al.
Publicado: (2015)

FoxM1 Directs STAT3 Expression Essential for Human Endometrial Stromal Decidualization
por: Jiang, Yaling, et al.
Publicado: (2015)

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
por: Zhang, Zhenfeng, et al.
Publicado: (2016)

FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition
por: Fei, Bao-Ying, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2018)

FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
por: Yu, Chun-Peng, et al.
Publicado: (2017)

FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2018)

Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas
por: Zeng, Wen‐Jing, et al.
Publicado: (2020)

A Cdh1–FoxM1–Apc axis controls muscle development and regeneration
por: Chen, Zhe, et al.
Publicado: (2020)

A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
por: Zhang, Yan-Ling, et al.
Publicado: (2021)

HPV Infection is Associated with FoxM1 Overexpression in Dysplastic Changes of Sinonasal Inverted Papilloma
por: Rachmadi, Lisnawati, et al.
Publicado: (2022)

β-Cell Proliferation, but Not Neogenesis, Following 60% Partial Pancreatectomy Is Impaired in the Absence of FoxM1
por: Ackermann Misfeldt, Amanda, et al.
Publicado: (2008)

Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1
por: Qian, Jianxin, et al.
Publicado: (2013)

The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia
por: Zhang, Xiaolu, et al.
Publicado: (2012)

Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma
por: Xue, Yi-Jun, et al.
Publicado: (2012)

MiR-29 Induces K562 Cell Apoptosis by Down-Regulating FoxM1
por: Wang, Xiaofang, et al.
Publicado: (2015)

Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
por: Pan, Huafeng, et al.
Publicado: (2018)

Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism
por: Yamamoto, Junpei, et al.
Publicado: (2017)

FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
por: Zhang, Chunli, et al.
Publicado: (2018)

ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
por: Jiao, Xiaodong, et al.
Publicado: (2018)

Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
por: Wang, Liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gt1cd6g5oqau2fu4268uetmlc8